Horizon Therapeutics PLC (NASDAQ:HZNP)

Delayed Data
As of May 18
 -4.48 / -4.82%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 12 analysts offering 12-month price forecasts for Horizon Therapeutics PLC have a median target of 140.00, with a high estimate of 162.00 and a low estimate of 132.00. The median estimate represents a +58.25% increase from the last price of 88.47.

Analyst Recommendations

The current consensus among 12 polled investment analysts is to Buy stock in Horizon Therapeutics PLC. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 0.30%
Growthannually 28.75%


Growthquarterly 5.90%
Growthannually 22.93%
Key to the earnings and sales forecast charts.